| scholarly article | Q13442814 |
| P50 | author | Monique Breteler | Q19609784 |
| Albert Hofman | Q30121906 | ||
| Lenore J Launer | Q66739234 | ||
| Jacqueline C M Witteman | Q105980953 | ||
| P2093 | author name string | Kalmijn S | |
| Ott A | |||
| P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study | Q36903154 | ||
| A case-control study of Alzheimer's disease in Australia | Q41198222 | ||
| Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors | Q48278329 | ||
| Dietary sodium, potassium, saturated fat, alcohol, and stroke mortality | Q49226836 | ||
| Prevalence of stroke in the general population. The Rotterdam Study. | Q51012822 | ||
| Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. | Q52005568 | ||
| Is silent cerebrovascular disease an important cause of late-life cognitive decline? | Q52009313 | ||
| Fish consumption and risk of stroke. The Zutphen Study. | Q55066104 | ||
| Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study | Q57782164 | ||
| P433 | issue | 5 | |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 776-782 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Dietary fat intake and the risk of incident dementia in the Rotterdam Study | |
| P478 | volume | 42 |
| Q44022196 | A convenient method for determination of the C20-22 PUFA composition of glycerolipids in blood and breast milk |
| Q35550684 | A diet enriched in docosahexanoic Acid exacerbates brain parenchymal extravasation of apo B lipoproteins induced by chronic ingestion of saturated fats |
| Q34406066 | A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. |
| Q36989464 | A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study |
| Q38287648 | A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning |
| Q24816672 | A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease |
| Q37456775 | A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease |
| Q33758695 | A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef |
| Q24531755 | A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease |
| Q48458709 | A unifying hypothesis of Alzheimer's disease. III. Risk factors |
| Q44155219 | ADHD is associated with a "Western" dietary pattern in adolescents |
| Q37692220 | APP Function and Lipids: A Bidirectional Link |
| Q51453604 | Abeta40 is associated with cognitive function, body fat and physical fitness in healthy older adults. |
| Q80279770 | Accelerated solvent extraction for quantitative measurement of fatty acids in plasma and erythrocytes |
| Q90590618 | Added sugar and dietary fiber consumption are associated with creativity in preadolescent children |
| Q36525556 | Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity |
| Q23911375 | Aging, stress and the hippocampus |
| Q50511973 | Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. |
| Q30244736 | Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics |
| Q26825442 | Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers |
| Q35806684 | Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin. |
| Q30251902 | Alzheimer's disease and diet: a systematic review |
| Q35841706 | Alzheimer's disease is a vasocognopathy: a new term to describe its nature |
| Q36994590 | Alzheimer's disease: the lipid connection |
| Q33889423 | An exploration of the role of a fish-oriented diet in cognitive decline: a systematic review of the literature |
| Q36122829 | An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II. |
| Q34754383 | Antioxidant strategies for Alzheimer's disease |
| Q28504715 | ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis |
| Q46535385 | Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application. |
| Q35515172 | Are certain lifestyle habits associated with lower Alzheimer's disease risk? |
| Q42736657 | Aronia melanocarpa treatment and antioxidant status in selected tissues in Wistar rats. |
| Q37678582 | Association between Dietary Sodium Intake and Cognitive Function in Older Adults |
| Q52650234 | Association between fish consumption and risk of dementia: a new study from China and a systematic literature review and meta-analysis. |
| Q33768448 | Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults |
| Q90718878 | Association of dietary ω-3 and ω-6 fatty acids intake with cognitive performance in older adults: National Health and nutrition examination Survey (NHANES) 2011-2014 |
| Q36753607 | Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study |
| Q35841709 | Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease |
| Q46490992 | Brain fatty acid profiles and spatial learning in malnourished rats: effects of nutritional intervention |
| Q38515312 | Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease |
| Q58793290 | Can inflammation be resolved in Alzheimer's disease? |
| Q24235237 | Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment |
| Q22242643 | Cardiovascular Risk Factors for Alzheimer's Disease |
| Q93159371 | Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons |
| Q97543764 | Changes of fat-mass and obesity-associated protein expression in the hippocampus in animal models of high-fat diet-induced obesity and D-galactose-induced aging |
| Q33969588 | Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets |
| Q36317585 | Cholesterol in Alzheimer's disease |
| Q35631400 | Cholinesterase inhibitors and vascular dementia: another string to their bow? |
| Q48161605 | Chronic consumption of a western diet modifies the DNA methylation profile in the frontal cortex of mice |
| Q48187646 | Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease |
| Q46153359 | Cognitive Function and Changes in Cognitive Function as Predictors of Incident Cardiovascular Disease: The Women's Health Initiative Memory Study |
| Q34465150 | Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects |
| Q46198511 | Cognitive deficit: another complication of diabetes mellitus? |
| Q46568948 | Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. |
| Q51947922 | Cognitive functions are not affected by dietary fatty acids in elderly subjects in the Pro.V.A. study population. |
| Q64901725 | Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors. |
| Q45850827 | Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids |
| Q48942518 | Cognitive recovery and restoration of cell proliferation in the dentate gyrus in the 5XFAD transgenic mice model of Alzheimer's disease following 2-hydroxy-DHA treatment |
| Q35540384 | Comparison between Alzheimer's disease and vascular dementia: Implications for treatment |
| Q30990060 | Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. |
| Q42488273 | Cortical cholinergic denervation elicits vascular A beta deposition. |
| Q33950420 | Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis |
| Q34222721 | Current and emerging drug treatment options for Alzheimer's disease: a systematic review. |
| Q37171159 | Current intakes of EPA and DHA in European populations and the potential of animal-derived foods to increase them |
| Q36633305 | DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older Adults. |
| Q35053868 | DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects |
| Q27023109 | Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms |
| Q93950045 | Dementia and statins |
| Q37263684 | Dementia prevention: methodological explanations for inconsistent results |
| Q42656272 | Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease |
| Q48656148 | Detrimental effects of a high fat/high cholesterol diet on memory and hippocampal markers in aged rats |
| Q41995767 | Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease |
| Q24646877 | Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease |
| Q35811859 | Diet and Alzheimer's disease: what the evidence shows. |
| Q22241476 | Diet and Alzheimer’s disease risk factors or prevention: the current evidence |
| Q38894485 | Diet and Dementia, is there a Link? A Systematic Review |
| Q38673312 | Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review. |
| Q51894821 | Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition). |
| Q64118633 | Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health |
| Q33815101 | Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus |
| Q39928314 | Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease |
| Q92755778 | Dietary Long-Chain Fatty Acids and Cognitive Performance in Older Australian Adults |
| Q33805341 | Dietary Risk Factors for Sporadic Creutzfeldt-Jakob Disease: A Confirmatory Case-Control Study |
| Q33935512 | Dietary fat composition and dementia risk |
| Q34018207 | Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study |
| Q36994819 | Dietary influences on cognitive function with aging: from high-fat diets to healthful eating |
| Q36993406 | Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly |
| Q34017726 | Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk |
| Q35113288 | Dietary lipids in the aetiology of Alzheimer's disease: implications for therapy |
| Q44189364 | Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion |
| Q36457368 | Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype |
| Q44569624 | Dietary supplement use in old age: associations with childhood IQ, current cognition and health |
| Q46885720 | Different effect of high fat diet and physical exercise in the hippocampal signaling. |
| Q44007731 | Discrepancies in dietary intakes and plasma concentrations of fatty acids according to age among Japanese female dietitians |
| Q24607545 | Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial |
| Q34123918 | Docosahexanoic acid and omega-3 fatty acids in depression |
| Q38649157 | Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders? |
| Q37413774 | Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients? |
| Q37475739 | Education attenuates the association between dietary patterns and cognition |
| Q36546521 | Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease |
| Q24170249 | Effects of aging and stress on hippocampal structure and function |
| Q80184580 | Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet |
| Q36866895 | Effects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled study |
| Q28533783 | Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice |
| Q48182034 | Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor |
| Q48155415 | Endogenous Docosahexaenoic Acid (DHA) Prevents Aβ1-42 Oligomer-Induced Neuronal Injury |
| Q92640130 | Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge |
| Q92757574 | Enhancing Omega-3 Long-Chain Polyunsaturated Fatty Acid Content of Dairy-Derived Foods for Human Consumption |
| Q33904779 | Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis |
| Q35920548 | Epidemiology of Alzheimer disease |
| Q33679242 | Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories |
| Q40284564 | Evidence for growth-promoting effects of omega n - 3 fatty acids alone and in combination with a specific vitamin and mineral complex in rat neuroblastoma cells |
| Q37833540 | Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain |
| Q38392909 | Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study |
| Q53277940 | Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. |
| Q47945490 | Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. |
| Q90726331 | Fatty Acids Compete with Aβ in Binding to Serum Albumin by Quenching Its Conformational Flexibility |
| Q33934660 | Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment |
| Q34411741 | Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease? |
| Q58393167 | Fish consumption among pregnant women in London, Ontario: associations with socio-demographic and health and lifestyle factors |
| Q33415119 | Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. |
| Q48061930 | Fish consumption, intake of fats and cognitive decline at middle and older age: the Doetinchem Cohort Study |
| Q34605131 | Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. |
| Q39748836 | Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice |
| Q33962080 | Fish, meat, and risk of dementia: cohort study |
| Q34022031 | Food combination and Alzheimer disease risk: a protective diet |
| Q58607672 | Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease |
| Q38763332 | Gamma-linolenic acid ameliorated glycation-induced memory impairment in rats. |
| Q35607880 | Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease |
| Q36369379 | High Fat Diet and Inflammation - Modulation of Haptoglobin Level in Rat Brain |
| Q46941970 | High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study |
| Q37076115 | High-Fat-Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders |
| Q33624475 | High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology |
| Q48697430 | Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up |
| Q35985536 | Homocysteine has anti-inflammatory properties in a hypercholesterolemic rat model in vivo |
| Q48497914 | Hyperpalatable Diet and Physical Exercise Modulate the Expression of the Glial Monocarboxylate Transporters MCT1 and 4. |
| Q28194417 | In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition |
| Q36287089 | Increased Consumption of Fruit and Vegetables Is Related to a Reduced Risk of Cognitive Impairment and Dementia: Meta-Analysis |
| Q46158132 | Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids |
| Q39958782 | Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels |
| Q44568049 | Influence of nutrition on cognitive function in a group of elderly, independently living people |
| Q45235256 | Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients |
| Q38557881 | Inspired by lipids: the Morton Lecture Award Presentation |
| Q33180953 | Intake of flavonoids and risk of dementia |
| Q24678388 | Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis |
| Q43269513 | Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: the Rotterdam Study |
| Q37421228 | Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study |
| Q35050945 | Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia |
| Q91675640 | Is Alzheimer's Disease Risk Modifiable? |
| Q28080008 | Is It Possible to Delay or Prevent Age-Related Cognitive Decline? |
| Q35236550 | Is the distinction between Alzheimer's disease and vascular dementia possible and relevant? |
| Q35836847 | Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers' Risk of Alzheimer's Disease |
| Q38659686 | Lifestyle Modulators of Neuroplasticity: How Physical Activity, Mental Engagement, and Diet Promote Cognitive Health during Aging. |
| Q22241490 | Lifestyle-related factors in predementia and dementia syndromes |
| Q36044934 | Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease |
| Q36508071 | Lipids and the pathogenesis of Alzheimer's disease: is there a link? |
| Q35467623 | Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease |
| Q37105436 | Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study |
| Q51949735 | Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. |
| Q34462761 | MIND diet associated with reduced incidence of Alzheimer's disease |
| Q35091730 | Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseases |
| Q33835559 | Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters |
| Q33740362 | Maternal high-fat diet worsens memory deficits in the triple-transgenic (3xTgAD) mouse model of Alzheimer's disease |
| Q33299024 | Measurement error adjustment in essential fatty acid intake from a food frequency questionnaire: alternative approaches and methods |
| Q34193658 | Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. |
| Q35917740 | Mediterranean diet and cognitive decline. |
| Q34508496 | Mediterranean diet and risk for Alzheimer's disease |
| Q48601711 | Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness |
| Q35663651 | Mental health care for the elderly in low-income countries: a health systems approach |
| Q92620152 | Metabolic Endotoxemia: A Potential Underlying Mechanism of the Relationship between Dietary Fat Intake and Risk for Cognitive Impairments in Humans? |
| Q46032053 | Metabolic links between diabetes and Alzheimer's disease. |
| Q35606922 | Midlife mental distress and risk for dementia up to 27 years later: the Nord-Trøndelag Health Study (HUNT) in linkage with a dementia registry in Norway |
| Q36244982 | Models and mechanisms of vascular dementia |
| Q37187559 | Neurological benefits of omega-3 fatty acids |
| Q53236058 | Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs. |
| Q24646914 | Neuroprotective and disease-modifying effects of the ketogenic diet |
| Q33647172 | Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation. |
| Q36844158 | Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors |
| Q33834876 | Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study |
| Q50646397 | Nutrient intake and cerebral metabolism in healthy middle-aged adults: Implications for cognitive aging. |
| Q35222298 | Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals |
| Q90355501 | Nutrients in the Prevention of Alzheimer's Disease |
| Q81441558 | Nutrition and aging. The Carla Workshop |
| Q38002363 | Nutrition and vascular dementia |
| Q38029587 | Nutrition, adult hippocampal neurogenesis and mental health |
| Q47967901 | Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function |
| Q37953987 | Nutritional determinants of cognitive aging and dementia |
| Q34420888 | Nutritional factors and Alzheimer's disease |
| Q38197701 | Nutritional management of older adults with cognitive decline and dementia |
| Q33684991 | Obesity increases cerebrocortical reactive oxygen species and impairs brain function |
| Q35670890 | Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan |
| Q37485311 | Olive oil and cognition: results from the three-city study |
| Q26782982 | Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia? |
| Q24244723 | Omega 3 fatty acid for the prevention of dementia |
| Q24246716 | Omega 3 fatty acid for the prevention of dementia |
| Q24234477 | Omega 3 fatty acids for the treatment of dementia and cognitive impairment |
| Q93078497 | Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials |
| Q38955402 | Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. |
| Q33602402 | Omega-3 fatty acids and dementia. |
| Q36361642 | Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review |
| Q38176274 | Omega-3 fatty acids: a growing ocean of choices |
| Q24595490 | Omega-3 fatty acids: potential role in the management of early Alzheimer's disease |
| Q34890890 | Omega-3 supplementation and loneliness-related memory problems: secondary analyses of a randomized controlled trial |
| Q38396432 | Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. |
| Q42677745 | On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks |
| Q92535585 | Ovarian Hormone-Dependent Effects of Dietary Lipids on APP/PS1 Mouse Brain |
| Q33556064 | Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation |
| Q47218201 | Palmitate induced C/EBP homologous protein activation leads to NF-κB -mediated increase in BACE1 activity and Amyloid beta genesis. |
| Q90656244 | Palmitate-Induced SREBP1 Expression and Activation Underlies the Increased BACE 1 Activity and Amyloid Beta Genesis |
| Q46714697 | Palmitate-induced Endoplasmic Reticulum stress and subsequent C/EBPα Homologous Protein activation attenuates leptin and Insulin-like growth factor 1 expression in the brain. |
| Q38939976 | Palmitic acid-induced neuron cell cycle G2/M arrest and endoplasmic reticular stress through protein palmitoylation in SH-SY5Y human neuroblastoma cells |
| Q35117457 | Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease |
| Q33905478 | Peroxisomal alterations in Alzheimer's disease |
| Q34566556 | Pharmacotheraphy for Alzheimer's disease |
| Q79274614 | Plasma Concentrations of (n-3) Highly Unsaturated Fatty Acids Are Good Biomarkers of Relative Dietary Fatty Acid Intakes: A Cross-Sectional Study |
| Q43558986 | Platelet secretion of beta-amyloid is increased in hypercholesterolaemia |
| Q34134545 | Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging |
| Q37607849 | Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. |
| Q44087186 | Prevalence of dementia in the older Japanese-Brazilian population |
| Q48915656 | Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats |
| Q50551596 | Rats Fed a Diet Rich in Fats and Sugars Are Impaired in the Use of Spatial Geometry. |
| Q35776495 | Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. |
| Q50000197 | Reduced cognitive function, increased blood-brain-barrier transport and inflammatory responses, and altered brain metabolites in LDLr -/-and C57BL/6 mice fed a western diet |
| Q43474027 | Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice |
| Q44520045 | Relevant activities of extracts and constituents of animals used in traditional Chinese medicine for central nervous system effects associated with Alzheimer's disease |
| Q36380198 | Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents |
| Q48453306 | Retrospective reports of dream characteristics and preferences for organic vs. junk foods |
| Q35131354 | Role of dietary pattern analysis in determining cognitive status in elderly Australian adults |
| Q51927804 | Screening for cognitive impairment in older adults attending an eye clinic. |
| Q26784170 | Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline |
| Q44125966 | Should the guidelines for monitoring serum cholesterol levels in the elderly be re-evaluated? |
| Q44125950 | Statin therapy for Alzheimer's disease: will it work? |
| Q36546516 | Statin therapy in Alzheimer's disease |
| Q43912948 | Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae |
| Q36608922 | Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance. |
| Q36209750 | The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome. |
| Q37132962 | The Erythrocyte Fatty Acid Profile and Cognitive Function in Old Chinese Adults |
| Q35665512 | The Postprandial Effects of a Moderately High-Fat Meal on Lipid Profiles and Vascular Inflammation in Alzheimer's Disease Patients: A Pilot Study. |
| Q41990404 | The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review |
| Q50774703 | The association between dairy product consumption and cognitive function in the National Health and Nutrition Examination Survey. |
| Q47641802 | The effect of a ketogenic diet versus a high-carbohydrate, low-fat diet on sleep, cognition, thyroid function, and cardiovascular health independent of weight loss: study protocol for a randomized controlled trial |
| Q48512402 | The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion |
| Q42414568 | The effect of vitamin E on neuronal apoptosis in hippocampal dentate gyrus in rabbits fed with high-cholesterol diets |
| Q36337340 | The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review |
| Q43988916 | The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease |
| Q46199976 | The impact of long-chain n-3 polyunsaturated fatty acids on human health. |
| Q36753395 | The impact of nutrition on cognition in the elderly. |
| Q37737857 | The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders |
| Q35576180 | The influences of diet and exercise on mental health through hormesis |
| Q35841731 | The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease |
| Q35533506 | The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy ol |
| Q38085660 | The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence |
| Q43225648 | The relationship between dietary lipids and cognitive performance in an elderly population |
| Q53286520 | The relationship between nutrient intake and cognitive performance in people at risk of dementia. |
| Q35618918 | The role of cardiovascular risk factors in Alzheimer's disease |
| Q33950413 | The role of cerebral ischemia in Alzheimer's disease |
| Q34999138 | The role of nutrition in Alzheimer's disease: epidemiological evidence |
| Q45083548 | The role of nutritional factors on the structure and function of the brain: an update on dietary requirements |
| Q39015985 | Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain |
| Q58321399 | Thirteen-year prospective study between fish consumption, long-chain N-3 fatty acids intakes and cognitive function |
| Q43500133 | Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. |
| Q36388561 | Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline? |
| Q92603575 | Tumor Necrosis Factor-Alpha Alters Electrophysiological Properties of Rabbit Hippocampal Neurons |
| Q36616575 | Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1 |
| Q30248800 | Using Multicountry Ecological and Observational Studies to Determine Dietary Risk Factors for Alzheimer's Disease |
| Q50420775 | VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: Consequences for cognitive function in humans. |
| Q36767965 | Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo |
| Q53235144 | Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. |
| Q33808042 | Vascular risk factors and Alzheimer's disease |
| Q33950366 | Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. |
| Q22251221 | Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity |
| Q24245462 | Yizhi capsule for vascular dementia |
| Q24246873 | Yizhi capsule for vascular dementia |
| Q24246123 | Zhiling decoction for vascular dementia |
| Q50996441 | [Lifestyle and cognition: what do we know from the aging and neurodegenerative brain?]. |
| Q80252373 | [Risk factors for Alzheimer: towards prevention?] |
| Q36891439 | n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study |
| Q34384913 | ω-3 fatty acids in the prevention of cognitive decline in humans |
Search more.